Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Food Allergy Treatment Market Set To Climb From $8.5 Billion In 2026 To $12.73 Billion By 2030
The food allergy treatment market size has seen rapid expansion in recent years. The market is projected to expand from $7.6 billion in 2025 to $8.5 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.8%. Factors contributing to this growth during the historic period include growth in food allergy prevalence, availability of antihistamines, adoption of epinephrine therapy, increased allergy diagnosis rates, and clinical guideline development.
The food allergy treatment market is projected to experience substantial expansion in the coming years. It is anticipated to reach $12.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast timeframe stems from advancements in oral immunotherapy, the proliferation of biologic remedies, an increase in pediatric allergy services, the necessity for sustained allergy control, and broader access to healthcare. Key trends for the upcoming period encompass a surge in the acceptance of immunotherapy-driven therapies, a rise in the utilization of epinephrine auto-injectors, a heightened emphasis on proactive allergy prevention, the broadening of customized allergy treatment approaches, and enhanced understanding of food allergy ailments.
Get A Free Sample Report With In-Depth Market Insights:
Food Allergy Treatment Market Growth Drivers: What’s Behind The Acceleration?
The rising incidence of food adulteration is anticipated to fuel the expansion of the food allergy treatment market in the future. Food adulteration involves the deliberate modification of food items, either by incorporating inferior, detrimental, or unapproved components, or by extracting essential ingredients, typically to boost volume or improve aesthetics, often compromising quality and safety. This surge in food adulteration stems from various factors, including economic advantages, intricate supply chains, insufficient regulatory oversight, technological advancements, a preference for convenience, globalized markets, environmental influences, consumer understanding, profit maximization, and inadequate enforcement of existing regulations. A primary driver behind the rise in food adulteration is the growing consumer demand for more affordable goods, which prompts manufacturers to reduce expenses and maximize earnings through morally questionable methods. The practice of food adulteration can elevate the likelihood of allergic responses by either introducing allergenic substances into food items or by jeopardizing the safety and purity of the food chain. For example, in 2023, data from the FDA CORE Network, a U.S. government agency, showed its team assessed 69 incidents, addressed 25, and released 10 public health advisories, contrasting with 65 incidents, 28 responses, and 11 advisories recorded in 2022. Consequently, the escalating problem of food adulteration is a significant impetus behind the expansion of the food allergy treatment market.
Food Allergy Treatment Market Segment Analysis: What Are The Core Market Categories?
The food allergy treatment market covered in this report is segmented –
1) By Drug Type: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anti-Cholinergic, Immuno-Modulators, Epinephrine, Immunotherapy
2) By Route Of Administration: Parenteral, Oral
3) By Allergen Type: Dairy Products, Poultry Product, Tree Nuts, Peanuts, Shellfish, Wheat, Soys, Other Allergens
4) By End-Use: Hospital Pharmacies, Retail Pharmacies, Other End-Uses
Subsegments:
1) By Antihistamines: Oral Antihistamines, Topical Antihistamines, Intranasal Antihistamines
2) By Decongestants: Oral Decongestants, Nasal Decongestants
3) By Corticosteroids: Oral Corticosteroids, Topical Corticosteroids, Intranasal Corticosteroids
4) By Mast Cell Stabilizers: Cromolyn Sodium, Nedocromil
5) By Leukotriene Inhibitors: Montelukast, Zafirlukast
6) By Nasal Anti-Cholinergic: Ipratropium Bromide
7) By Immuno-Modulators: Omalizumab, Dupilumab
8) By Epinephrine: Injectable Epinephrine, Auto-Injectors
9) By Immunotherapy: Oral Immunotherapy (OIT), Sublingual Immunotherapy (SLIT), Epicutaneous Immunotherapy (EPIT)
Food Allergy Treatment Market Trends Redefining Industry Growth
Key companies in the food allergy treatment market are advancing innovative therapies, such as monoclonal antibodies, to tackle the fundamental mechanisms of food allergies and deliver more effective patient care. Monoclonal antibodies offer a promising strategy for managing food allergies by specifically targeting immune system components involved in allergic reactions, thus providing more effective and precise treatments for patients. For example, in February 2024, Novartis AG, a pharmaceutical firm based in Switzerland, secured FDA approval for Xolair (omalizumab) to diminish IgE-mediated food allergies. This humanized monoclonal antibody, administered subcutaneously, functions by impeding the binding of IgE antibodies, thereby reducing the release of chemicals responsible for allergy symptoms. The FDA’s approval is underpinned by positive outcomes from the Phase III OUtMATCH study, which indicated that a substantially higher proportion of food allergy patients, including those as young as 1 year, who were treated with Xolair, could tolerate small quantities of peanut, milk, egg, and cashews without an allergic reaction, when compared to the placebo group.
Food Allergy Treatment Market Top Companies Driving Competitive Growth
Major companies operating in the food allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, Novartis AG, Amgen Inc., Regeneron Pharmaceuticals Inc., ALK-Abelló A/S, Stallergenes Greer, Kaleo Inc., HAL Allergy B.V., Vedanta Biosciences Inc., Aimmune Therapeutics, AnaptysBio Inc., Immunomic Therapeutics Inc., Alladapt Immunotherapeutics Inc., Aravax, Prota Therapeutics Pty Ltd., DBV Technologies, Adamis Pharmaceuticals Corporation
View The Full Food Allergy Treatment Market Report:
Food Allergy Treatment Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the food allergy treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food allergy treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
